A group of experts who reviewed evidence on urinary tract infections (UTIs) failed to come up with many recommendations due to the lack of evidence about how to diagnose and treat the infections ...

While primary care physicians are generally comfortable prescribing vaginal estrogen therapy for recurrent urinary tract infections (UTIs), other nonantibiotic prophylactic options remain ...

Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

The FDA on Friday signed off on Iterum Therapeutics’ oral antibiotic sulopenem etzadroxil and probenecid, which will now be marketed as Orlynvah, for the treatment of uncomplicated urinary tract ...

Patterson-UTI Energy has impressed us by growing EPS at 44% per year over the past five years. While the company is not yet turning a profit, it is growing at a good rate. If profitability can be ...

Patterson-UTI Energy Inc., one of the largest contract drillers in the United States, is not expecting a recovery in activity or natural gas development next year because of delays in bringing ...